Remove news experimental-ai-predicts-whether-cancer-drugs-will-work
article thumbnail

JPM2023: Breakthroughs await, but so do roadblocks

pharmaphorum

And as I look out the window at that snow, my travel-addled brain can’t help but see it as a metaphor for pharma in 2023: a crisp white, wide canvas laden with possibilities, but also one that’s going to require a lot of immediate, hard work from me if I want to be a responsible homeowner. Alright, throw me in metaphor jail. I deserve it.

article thumbnail

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

From rare disease drug approvals to treatments involving immunotherapies and gene therapies and awarding of a Nobel Prize to the inventors of the gene-editing tool CRISPR, 2020 was a year of great activity and productivity despite the backdrop of the pandemic. It was a failure of governance, and that’s a big lesson.